Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2022
Mar. 31, 2021
Current assets:    
Cash and cash equivalents $ 125.0 $ 208.5
Restricted cash and cash equivalents 5.0 5.0
Restricted cash and cash equivalents - Asbestos 141.9 104.9
Restricted short-term investments - Asbestos 119.7 26.6
Accounts and other receivables, net 398.4 333.2
Inventories 279.7 218.3
Prepaid expenses and other current assets 43.2 38.9
Insurance receivable - Asbestos 7.9 6.6
Workers’ compensation - Asbestos 3.2 1.6
Total current assets 1,124.0 943.6
Property, plant and equipment, net 1,457.0 1,372.3
Operating lease right-of-use-assets 57.8 46.4
Finance lease right-of-use-assets 2.3 2.7
Goodwill 199.5 209.3
Intangible assets, net 162.8 173.9
Insurance receivable - Asbestos 37.8 42.9
Workers’ compensation - Asbestos 18.6 20.3
Deferred income taxes 819.2 906.8
Deferred income taxes - Asbestos 360.1 367.4
Other assets 4.1 3.4
Total assets 4,243.2 4,089.0
Current liabilities:    
Accounts payable and accrued liabilities 458.0 307.0
Accrued payroll and employee benefits 116.6 112.5
Operating lease liabilities 12.5 7.8
Finance lease liabilities 1.1 1.0
Accrued product warranties 6.7 6.0
Income taxes payable 9.5 6.6
Asbestos liability 132.9 122.2
Workers’ compensation - Asbestos 3.2 1.6
Dividends payable 0.0 303.7
Other liabilities 29.4 32.7
Total current liabilities 769.9 901.1
Long-term debt 877.3 858.6
Deferred income taxes 86.9 86.3
Operating lease liabilities 63.1 53.3
Finance lease liabilities 1.5 1.9
Accrued product warranties 31.0 33.6
Income taxes payable 2.3 4.7
Asbestos liability 1,010.8 1,013.6
Workers’ compensation - Asbestos 18.6 20.3
Other liabilities 48.9 54.8
Total liabilities 2,910.3 3,028.2
Commitments and contingencies (Note 14)
Shareholders’ equity:    
Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 445,348,933 shares issued and outstanding at 31 March 2022 and 444,288,874 shares issued and outstanding at 31 March 2021 232.1 231.4
Additional paid-in capital 230.4 224.6
Retained earnings 892.4 611.4
Accumulated other comprehensive loss (22.0) (6.6)
Total shareholders’ equity 1,332.9 1,060.8
Total liabilities and shareholders’ equity $ 4,243.2 $ 4,089.0